The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...

Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

After several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...